Medicine and Dentistry
Patient
100%
Survival
23%
Non Small Cell Lung Cancer
19%
Predictor
15%
Overall Survival
11%
Therapeutic Procedure
11%
Histology
7%
Prognostic Factor
7%
Progression Free Survival
7%
Serositis
3%
Multivariate Analysis
3%
Malignant Neoplasm
3%
Kaplan Meier Method
3%
Anaplastic Carcinoma
3%
Analysis
3%
Blood
3%
Indicator
3%
Clinical Significance
3%
Immunology and Microbiology
Lymphocyte
65%
Neutrophil Granulocyte
65%
Survival
23%
Cells
19%
Lung
19%
Overall Survival
11%
Progression Free Survival
7%
Blood Product
3%
Systemic Inflammation
3%
Electric Potential
3%
Gender
3%
Nursing and Health Professions
Neutrophil Lymphocyte Ratio
65%
Survival
23%
Non Small Cell Lung Cancer
19%
Inpatient
15%
Overall Survival
11%
Chemotherapy
11%
Histology
7%
Progression Free Survival
7%
Gender
7%
Prognosis
3%
Multivariate Analysis
3%
Inflammation
3%
Kaplan Meier Method
3%
Electric Potential
3%
Procedures
3%
Malignant Neoplasm
3%
Indicator
3%
Analysis
3%
Anaplastic Carcinoma
3%
Neuroscience
Lymphocyte
65%
Chemotherapy
11%
Histology
7%
Pharmacology, Toxicology and Pharmaceutical Science
Survival
23%
Non Small Cell Lung Cancer
19%
Overall Survival
11%
Progression Free Survival
7%
Inflammation
3%
Prognosis
3%
Malignant Neoplasm
3%
Indicator
3%
Anaplastic Carcinoma
3%